Kit offers novel protein interactomics analysis of immune cells MORRISVILLE, N.C. and STOCKHOLM -- Carolina Molecular Inc., a leading molecular testing services laboratory, and Pixelgen Technologies AB announced today a partnership to expand access to cutting-edge 3D protein interactomics capabilities to researchers and clinicians in the United States. Carolina Molecular will be the first certified U.S. service provider for [...]

NATICK, Mass. -- Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a research-use-only (RUO) next-generation sequencing (NGS) kit designed to enable laboratories to perform rapid tumor profiling of lymphoid malignancies. The oncoReveal Lymphoid panel interrogates 84 genes of interest, including full coding DNA sequence (CDS) of 29 genes with a [...]

Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. CAMBRIDGE, Mass. and SAN DIEGO, Calif. — Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the two [...]

Custom antibody service provides research antibodies that always work—for any target, any species PHILADELPHIA -- Cell Surface Bio (CSB) announces the launch VeRSa-Select™, a custom antibody service providing scientists with unparalleled access to the highest quality antibody reagents in the industry for any protein target. These include challenging and structurally complex targets such as GPCRs and ion channels, [...]

TORONTO & MONTREAL -- BenchSci, a leading provider of AI software for biopharma research and development, and Mila - Quebec Artificial Intelligence Institute, one of the world’s premier AI research centers, today announced a multi-year partnership to advance the use of artificial intelligence for biological inference. As part of this partnership, BenchSci and Mila will [...]

FRAMINGHAM, Mass. -- SCIEX, a global leader in life science analytical technologies, announces the localization of its X500R QTOF system, ZenoTOF 7600 system, and ZenoTOF 7600+ system in China. This strategic advancement underscores the company’s continued commitment to accelerate localization efforts for its products in China, building upon the successful localization of the entire current [...]

Partnership underscores Agilent’s expansion across Asia, including recent establishment of Centres of Excellence within flagship university campuses in South Korea, Singapore and Malaysia MELBOURNE, Australia -- Agilent Technologies Inc. (NYSE: A) announced the launch of its new Agilent Innovation Hub in partnership with the University of Melbourne, acting through the Australian Laboratory for Emerging Contaminants (ALEC). The [...]

DURHAM, NC -- EpiCypher®, a leader in chromatin biology and epigenetics, today announced the launch of its CUTANA® Fiber-seq Kit and the exclusive licensing of key Fiber-seq technology from the Altius Institute for Biomedical Sciences. This milestone marks a major step toward making advanced chromatin fiber mapping technology accessible to researchers around the world. Fiber-seq, developed at [...]

BOSTON and SAN DIEGO -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research supporting [...]

Company initiates search for successor ROCKVILLE, Md. -- MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that Chief Financial Officer Douglas Swirsky has informed the Company of his decision to transition from his role in the first [...]